TEST REPORT

Name : Mr. DEVENDRA SINGH Acc. ID 214033466

Age/Sex : 33 Years / Male Birthdate : Regd. Dt : 01-Apr-2021 01:10 PM

Refd. By : SELF Status : Final Coll Dt. TM. :

Sample : Naso and Oropharyngeal Swab Mobile : 8764315579 Recd. Dt. Tm. : 01-Apr-2021 01:10 PM

Client Details : RACECOURSE LAB Report Dt. Tm. : 01-Apr-2021 07:57 PM

SARS-CoV-2 (nCOVID-19) QUALITATIVE DETECTION BY RT-PCR
Method: Qualitative Real Time PCR by Quantstudio 5 (ABI) Thermo Scientific, USA ICMR Reg No: PACAPALABVG

COVID 19 Test Result Negative

INTERPRETATION:

Cycle threshold (Ct Value) Value ranges from 15-40 cycle.

Lower the Ct value higher is the viral load (Inversely proportion).
High viral load: Ct < 24 Moderate viral load: Ct 24 to 31 Low/Mild viral load: CT > 31
(Note: Viral load differentiation is for better understanding of diseased condition and patient treatment. According to latest CDC
guideline, Ct cut-off of more than 33 is not considered as infective as it is extremely difficult to detect any live virus in sample
above the threshold of 33 cycles. Low viral load must be correlated with clinical and radiological for better interpretation).

LIMITATIONS:

• The results of this test are highly dependent on the sampling technique employed, sample type, cold-chain
maintenance and clinical condition.
• Presence of PCR inhibitors (cannot be traced by technologist), specimen collected very early/late in infection
(Optimum specimen types and timing for peak viral levels during infections caused by 2019-nCoV have not
been determined) or viral load lesser than the assay lower limit of detection as well as presence of rare
genotypes or viral mutations may result in false-negative report (Technical reasons).
• The LOD for the three target genes is 10 GEC/reaction (GEC: Genomic copy Equivalents).
• A negative result does not rule out 2019-nCoV and should not be used as the sole basis for treatment or other
patient management decisions.
• Collection of multiple samples from the same patient may be necessary to detect the virus.
• False-positive report may be obtained in cases where there is possibility of background RNA contamination
from pre analytical or in lab environment.
• There is poor standardization between commercially available PCR tests, and results from different institutions
should not be directly compared. Results are best monitored using a single institution.

This is an Electronically Authenticated Report.

DR VIRAL PATEL. Dr. VIRAL A. PATEL

Verified By
M. D. PATHOLOGY M. D. PATHOLOGY
GMC No. G-22658 ISHITA MEHTA GMC No. G-22658
Page 1 of 2
 TEST REPORT
Name : Mr. DEVENDRA SINGH Acc. ID : 214033466
Age/Sex : 33 Years / Male Birthdate : Regd. Dt : 01-Apr-2021 01:10 PM
Refd. By : SELF Status : Final Coll Dt. TM. :
Sample : Naso and Oropharyngeal Swab Mobile 8764315579 Recd. Dt. Tm. : 01-Apr-2021 01:10 PM
Client Details : RACECOURSE LAB Report Dt. Tm. : 01-Apr-2021 07:57 PM
COMMENTS:

• The assay is for in vitro diagnostic use under the FDA Emergency Use Authorization Only.
• Reports will be provided to the treating physician, who is requested to communicate the same to the patient
and follow MOHFW policy for isolation, quarantine and treatment of all positive cases along with contact tracing
as recommended.
• Repeat sampling and testing of lower respiratory specimen is strongly recommended in severe or progressive
disease.
• The repeat specimens may be considered after a gap of 2-4 days after the collection of the first specimen for
additional testing if required.

End Of Report

This is an Electronically Authenticated Report.

DR VIRAL PATEL. Dr. VIRAL A. PATEL

Verified By
M. D. PATHOLOGY M. D. PATHOLOGY
GMC No. G-22658 ISHITA MEHTA GMC No. G-22658
Page 2 of 2